Connor Iapoce is an associate editor for HCPLive and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at ciapoce@mjhlifesciences.com.
Andres Emanuelli, MD: Analysis of the Port Delivery System in the Phase 3 Pavilion Trial
May 3rd 2023At ARVO 2023, Emanuelli discusses the primary analysis results of the phase 3 Pavilion trial evaluating the PDS with ranibizumab in patients with diabetic retinopathy without center-involved diabetic macular edema.
Read More
Cardiology Month in Review: April 2023
May 2nd 2023Each month, our editorial staff compiles a recap of the top news in cardiology from the past month. Our April 2023 month in review features new data and documents related to heart failure management, recaps and forecasts of top regulatory decisions, and other top news!
Read More
Carl Danzig, MD: Analysis of GATHER Trials Connects GA Growth with Vision Loss
April 24th 2023In an interview at ARVO 2023, Danzig discusses the post-hoc analysis from the GATHER trials, showing that a reduced rate of vision loss in patients receiving avacincaptad pegol was correlated with reduced GA growth.
Read More
Caroline Baumal, MD: Marking a New Treatment Era for GA with Pegcetacoplan
April 24th 2023At ARVO 2023, Caroline Baumal, MD, chief medical officer of Apellis Pharmaceuticals, discussed new phase 3 functional analyses of pegcetacoplan injection, the future of the GA treatment landscape, and the next unmet need in ophthalmology.
Read More
SB15 Demonstrates Similar Efficacy to Reference Aflibercept in nAMD at 56 Weeks
April 24th 2023Phase 3 results presented at ARVO 2023 suggest a switch from aflibercept to SB15 led to no treatment-emergent issues such as loss of efficacy, increased adverse events, or increased immunogenicity.
Read More
New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD
April 23rd 2023As part of our ARVO 2023 coverage, Dr. Sheth sat down with Pravin Dugel, MD, President of Iveric Bio to discuss avacincaptad pegol for geographic atrophy and a look back at Dr. Dugel's career and his transition into industry.
Read More
Healthy Beverage Choices May Lower Mortality Risk in Adults with Diabetes
April 20th 2023An analysis of adults with T2D found a higher intake of sugar-sweetened beverages was associated with higher all-cause mortality and CVD incidence, whereas healthier beverage options were inversely associated with all-cause mortality.
Read More